Evidence map›Paper›PMID 32071385›Full record

ArticleMolecular psychiatry2021

Inhibition of colony stimulating factor 1 receptor corrects maternal inflammation-induced microglial and synaptic dysfunction and behavioral abnormalities.

Seiko Ikezu, Hana Yeh, Jean-Christophe Delpech, Maya E Woodbury, Alicia A Van Enoo, Zhi Ruan, Sudhir Sivakumaran, Yang You, Carl Holland, Teresa Guillamon-Vivancos and 12 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microglia as critical mediators linking perinatal immune stress to mental health trajectories.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  6. Microglial plasticity across development mediates infantile amnesia.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Seiko Ikezu *Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA. sikezu@bu.edu.
Hana Yeh *Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Jean-Christophe Delpech *Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Maya E Woodbury *Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Alicia A Van EnooDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Zhi RuanDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Sudhir SivakumaranAnatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8586-0469
Yang YouDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0574-7827
Carl HollandAnatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Teresa Guillamon-VivancosAnatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Asuka Yoshii-KitaharaDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Mina B BotrosDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Charlotte MadoreAnn Romney Center for Neurologic Diseases, Department of Neurology and Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Pin-Hao ChaoDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3766-0419
Ankita DesaniDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Solaiappan ManimaranComputational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
Srinidhi Venkatesan KalavaiDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
W Evan JohnsonComputational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
Oleg ButovskyAnn Romney Center for Neurologic Diseases, Department of Neurology and Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0186-8867
Maria MedallaAnatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Jennifer I LuebkeAnatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Tsuneya IkezuDepartments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA. tikezu@bu.edu.ORCID http://orcid.org/0000-0002-3979-8596

Funding

Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Exosome-mediated propagation of pathogenic tau proteinRF1AG054199 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2016 to 2021
$5.0M
Targeting TGFb/IFNy-IRF8 Signaling to Modulate Monocytes and their Crosstalk with Microglia and Astrocytes to Treat Multiple SclerosisR01NS088137 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Oleg Butovsky · 2014 to 2026
$4.9M
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimer’s diseaseR01AG054672 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI BUTOVSKY, OLEG, IKEZU, TSUNEYA · 2017 to 2021
$4.1M
Biogenesis of Exosomes, Secretion, and Trafficking in Alzheimer's DiseaseR56AG057469 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H, IKEZU, TSUNEYA · 2017 to 2017
$833k
BLRD VA I01 BX003040NIA NIH HHS P30 AG013846NIA NIH HHS P30 AG072978NIA NIH HHS R01 AG054672NIA NIH HHS R56 AG057469NIA NIH HHS RF1 AG054199NIGMS NIH HHS T32 GM008541NINDS NIH HHS R01 NS088137
6 · The paper itself

Abstract

Maternal immune activation (MIA) disrupts the central innate immune system during a critical neurodevelopmental period. Microglia are primary innate immune cells in the brain although their direct influence on the MIA phenotype is largely unknown. Here we show that MIA alters microglial gene expression with upregulation of cellular protrusion/neuritogenic pathways, concurrently causing repetitive behavior, social deficits, and synaptic dysfunction to layer V intrinsically bursting pyramidal neurons in the prefrontal cortex of mice. MIA increases plastic dendritic spines of the intrinsically bursting neurons and their interaction with hyper-ramified microglia. Treating MIA offspring by colony stimulating factor 1 receptor inhibitors induces depletion and repopulation of microglia, and corrects protein expression of the newly identified MIA-associated neuritogenic molecules in microglia, which coalesces with correction of MIA-associated synaptic, neurophysiological, and behavioral abnormalities. Our study demonstrates that maternal immune insults perturb microglial phenotypes and influence neuronal functions throughout adulthood, and reveals a potent effect of colony stimulating factor 1 receptor inhibitors on the correction of MIA-associated microglial, synaptic, and neurobehavioral dysfunctions.

Indexed as

MicrogliaPrenatal Exposure Delayed EffectsAnimalsBehavior, AnimalBrainDisease Models, AnimalFemaleInflammationMacrophage Colony-Stimulating FactorMiceNeuronsPregnancyReceptors, Granulocyte-Macrophage Colony-Stimulating FactorCsf1r protein, mouseMacrophage Colony-Stimulating FactorReceptors, Granulocyte-Macrophage Colony-Stimulating Factor

Identifiers

PMID32071385
PMCPMC7431382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.